Financial News
Bluebird Bio (NQ: BLUE )
0.4636
-0.2764
(-37.35%)
Streaming Delayed Price
Updated: 11:02 AM EST, Dec 5, 2024
Add to My Watchlist
Headline News about Bluebird Bio
FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
November 29, 2024
Via Benzinga
Exposures
Product Safety
Exploring bluebird bio's Earnings Expectations
November 13, 2024
Via Benzinga
The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts
September 25, 2024
Via Benzinga
What 4 Analyst Ratings Have To Say About bluebird bio
August 15, 2024
Via Benzinga
Earnings Scheduled For November 14, 2024
November 14, 2024
Via Benzinga
Via Benzinga
Peering Into bluebird bio's Recent Short Interest
March 22, 2024
Via Benzinga
Via Benzinga
Via Benzinga
(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 26, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.